Peptide Synthesis Market Size

  • Report ID: 4800
  • Published Date: Jun 17, 2024
  • Report Format: PDF, PPT

Peptide Synthesis Market Size

Peptide Synthesis Market size was over USD 606.73 Million in 2023 and is projected to exceed USD 1.46 Billion by the end of 2036, witnessing over 7.1% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of peptide synthesis is evaluated at USD 683.91 Million. The market growth can be attributed to the escalating integration of precision medicines and the high demand for personalized medicine. The development of personalized medicines enables doctors to tailor treatments to each individual patient’s oriented needs and characteristics. Thus, with increasing investment in the R&D of precise medicines the demand for peptide synthesis is expected to increase in the future.

Besides, there are more factors behind the expansion of the peptide synthesis market such as rising emphasis on protein-based therapeutics such as recombinant proteins, and the high prevalence of cardiovascular diseases, reported by the World Health Organization every year around 17.9 million deaths take place globally due to cardiovascular diseases.


Peptide Synthesis Market overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Rajrani Baghel


  • Report ID: 4800
  • Published Date: Jun 17, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of peptide synthesis is evaluated at USD 683.91 Million.

The peptide synthesis market size was over USD 606.73 Million in 2023 and is projected to exceed USD 1.46 Billion by the end of 2036, witnessing over 7.1% CAGR during the forecast period i.e., between 2024-2036. Growing expenditure by the pharmaceutical industry on R&D along with growth in drug approvals and high usage in COVID-19 treatment are some of the major factors anticipated to drive the growth of the market.

North America industry is slated to dominate reveue share by 2036, backed by government and academic institutions increasing efforts to create innovative peptide-based medicinal pharmaceuticals in the region.

CordenPharma International, Evonik, CSBio Company Inc., Bachem Holding, AGBiotage, AAPP Tec, CEM Corporation, ProteoGenix, GenScript, Thermo Fisher Scientific Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying